Advanced Biomed (NASDAQ: ADVB) investors approve all 2026 meeting proposals
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Advanced Biomed Inc. reported the results of its annual stockholder meeting held on June 30, 2026, where all five proposals passed. Stockholders elected five directors, approved executive compensation on a non-binding basis, and chose annual advisory votes on pay.
Holders of 1,422,573.80 common shares were represented, about 86.105% of the 1,652,133 shares outstanding and entitled to vote as of May 29, 2026, establishing a quorum. Stockholders also ratified WWC, P.C. as auditor for the fiscal year ending June 30, 2026, and approved a potential adjournment of the meeting if needed.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares represented at meeting: 1,422,573.80 shares
Shares outstanding entitled to vote: 1,652,133 shares
Quorum percentage: 86.105%
+5 more
8 metrics
Shares represented at meeting
1,422,573.80 shares
Common stock present in person or by proxy at June 30, 2026 meeting
Shares outstanding entitled to vote
1,652,133 shares
Common stock issued, outstanding and entitled to vote as of May 29, 2026
Quorum percentage
86.105%
Portion of entitled shares represented at the annual meeting
Votes for CEO director Xiaomin Chen
1,296,710.80 votes
For votes in director election, with 49,755.00 against/withheld
Say-on-pay for votes
1,346,420.80 votes
Non-binding advisory approval of named executive officer compensation
Auditor ratification for votes
1,422,573.80 votes
Votes in favor of ratifying WWC, P.C. as auditor for fiscal year ending June 30, 2026
Say-on-pay frequency one-year votes
1,346,420.60 votes
Votes favoring annual advisory votes on executive compensation
Adjournment proposal for votes
1,422,537.80 votes
Votes approving potential adjournment to solicit additional proxies
Key Terms
non-binding, advisory basis, Say-on-Pay, Broker Non-Votes, independent registered public accounting firm, +1 more
5 terms
non-binding, advisory basis regulatory
"To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers"
A non-binding, advisory basis means a recommendation or decision that carries no legal force and does not obligate the parties to act; it’s similar to a friendly suggestion rather than a signed promise. For investors, this matters because such guidance can influence market expectations and management plans but offers no guarantee of follow-through, so investors should treat it as informative input rather than a firm commitment.
Say-on-Pay financial
"the compensation of the Company’s named executive officers as disclosed in the proxy statement (“Say-on-Pay”)."
A say-on-pay is a shareholder vote that gives investors a chance to approve or disapprove a company’s executive compensation packages, typically held at annual meetings. It matters because the vote signals investor satisfaction with how leaders are paid—like customers rating how well managers are rewarded—and can push boards to change pay plans, reducing governance risk and affecting investor confidence and stock value even though the vote is usually advisory rather than legally binding.
Broker Non-Votes regulatory
"Abstentions | | Broker Non-Votes 1,346,420.80 | | 45.00 | | 0.00 | | 76,108.00"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"To ratify the appointment of WWC, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026."
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
quorum regulatory
"representing approximately 86.105% of the 1,652,133 shares ... and therefore constituting a quorum."
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
FAQ
What say-on-pay decisions did Advanced Biomed (ADVB) investors make in 2026?
Investors approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 1,346,420.80 votes for, 45.00 against or withheld, no abstentions, and 76,108.00 broker non-votes. They also recommended holding future advisory say-on-pay votes every one year.
What quorum was achieved at Advanced Biomed’s June 30, 2026 annual meeting?
The meeting achieved a quorum with 1,422,573.80 shares of common stock represented. This equaled roughly 86.105% of the 1,652,133 shares issued, outstanding, and entitled to vote as of the May 29, 2026 record date for the annual stockholder meeting.